These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10891848)

  • 1. Administration of blood products.
    McMahon M
    Int J Trauma Nurs; 2000; 6(3):95-100. PubMed ID: 10891848
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood transfusion.
    Nerlich S
    Aust Nurs J; 1998 Jun; 5(11):suppl i-iv. PubMed ID: 10639966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood component replacement therapy.
    Coffland FI; Sheleton DM
    Crit Care Nurs Clin North Am; 1993 Sep; 5(3):543-56. PubMed ID: 8217049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heparinized venous approaches].
    Arnáiz Betolaza L; Novoa Vences E
    Rev Enferm; 1996 May; 19(213):64-5. PubMed ID: 8716873
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood transfusion and monitoring. Blood products for transfusion. Indications].
    Gaspard M
    Soins; 1996 Apr; (605):18-9. PubMed ID: 8716243
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood products].
    Montloin A
    Rev Infirm; 1992 Mar; 42(6):33-41. PubMed ID: 1598492
    [No Abstract]   [Full Text] [Related]  

  • 7. Current trends in blood component therapy: the evolution of a safer, more effective product.
    Baranowski L
    J Intraven Nurs; 1992; 15(3):136-51. PubMed ID: 1608013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal blood component therapy.
    Armentrout D; Getz SL
    J Perinat Neonatal Nurs; 1998 Dec; 12(3):50-66. PubMed ID: 10326433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood component therapy and changing transfusion triggers.
    Williford PD; Bensky KP
    CRNA; 1994 Nov; 5(4):139-50. PubMed ID: 7881351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Viral inactivation of cellular blood products].
    Andreu G
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):215-6. PubMed ID: 8337130
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood component therapy in obstetrics.
    Fuller AJ; Bucklin B
    Obstet Gynecol Clin North Am; 2007 Sep; 34(3):443-58, xi. PubMed ID: 17921009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward reducing perioperative transfusions.
    Joyce JA
    AANA J; 2008 Apr; 76(2):131-7. PubMed ID: 18478819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When to administer modified blood products.
    Fitzpatrick L
    Nursing; 2002 May; 32(5):36-41; quiz 42. PubMed ID: 12035651
    [No Abstract]   [Full Text] [Related]  

  • 14. Perioperative blood management.
    Geier K
    Orthop Nurs; 1998; 17(1 Suppl):6-36; quiz 37-8. PubMed ID: 9526414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of blood products in shock.
    Nacht A
    Crit Care Clin; 1992 Apr; 8(2):255-91. PubMed ID: 1568140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications for labile blood products].
    Jeanne M; Rasonglès P
    Rev Prat; 2001 Jun; 51(12):1318-27. PubMed ID: 11503505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood component therapy.
    Fasano R; Luban NL
    Pediatr Clin North Am; 2008 Apr; 55(2):421-45, ix. PubMed ID: 18381094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood transfusion: the high-risk life-saving therapy.
    Casey G
    Nurs N Z; 2011 May; 17(4):20-5. PubMed ID: 21736112
    [No Abstract]   [Full Text] [Related]  

  • 19. Current and future trends in transfusion therapy.
    Rossetto CL; McMahon JE
    J Pediatr Oncol Nurs; 2000 Jul; 17(3):160-73. PubMed ID: 10944864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autohemotransfusion].
    Stefanova A
    Akush Ginekol (Sofiia); 2003; 42(4):21-7. PubMed ID: 14577364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.